Verdict Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Journal 2019, Issue 44

Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.

Emerging pharma hubs are springing up across the world and this provides us with many more options on where to place our valuable assets.

NSF is noticing a trend where a variety of pharma companies want a third-party perspective on the suitability of an outsourcing option, seeking a thorough and impartial assessment of risk, distinctly outside of the influence of internal politics and financial targets.

From such a review, NSF can measure the resource burden of setting up and providing ongoing monitoring of the outsourced location, the inherent risks and how to identify and manage them effectively.

Download to find out more.


Driving towards the implementation of the new Medical Devices Regulations (MDR)

  On 5 April 2017, two new Medical Devices Regulations (MDR) on medical devices were adopted, and they entered into…
Read More…


Go Top